Back to Selection     Print       Date : 31 Mar 2025
Fund Summary
DSP Healthcare Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 30-Nov-2018
Corpus(Cr.) 3019.0 Latest NAV 37.839 As on 30-05-2025
Equity(%) 85.55 52 Week High 41.92
Debt(%) 0.82 52 Week Low 31.503
Others(%) 0.0 Exit Load 0.5% for redemption within 1 month
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.93
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Chirag Dagli
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 42.38%
Top 10 Holdings 64.43%
Top 25 Holdings 97.40%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 69.9
Healthcare 13.74
Global Equity 13.63
Miscellaneous 1.43
Cash 0.82
Retail 0.48
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.03
PE Ratio 42.65
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 10.78
Suven Pharmaceuticals Limited 9.49
Cipla Limited 8.55
IPCA Laboratories Limited 7.98
Globus Medical Inc 5.58
Gland Pharma Limited 4.86
Laurus Labs Limited 4.51
ALEMBIC PHARMACEUTICALS 4.38
Apollo Hospitals Enterprise Limited 4.27
Sai Life Sciences Limited 4.03
Illumina Inc 3.61
VIJAYA DIAGNOSTIC CENTRE LIMITED 3.40
Kovai Medical Center & Hospital Ltd 2.83
Concord Biotech Limited 2.73
Procter & Gamble Health Limited 2.71
Pfizer Limited 2.66
Intuitive Surgical Inc 2.64
Indoco Remedies Limited 2.49
Unichem Laboratories Limited 1.95
Narayana Hrudalaya Ltd 1.80
ICICI LOMBARD GENERAL INSURANC 1.43
TREPS / Reverse Repo Investments 1.35
Emcure Pharmaceuticals Limited 1.22
Abbott Laboratories 1.19
Aarti Drugs Limited 0.96

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
1.94% 4.82% -8.78% 18.61%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.92% 12.13% 3.05% 11.08%
 
Scheme Benchmark [BSE Healthcare TRI]
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
30.64% 23.29% 23.68% 0.00%
 
 
16.89% 15.56% 22.29% 12.73%
 
 
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection